vs

Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and Qualcomm (QCOM). Click either name above to swap in a different company.

ASTRAZENECA PLC is the larger business by last-quarter revenue ($14.5B vs $12.3B, roughly 1.2× Qualcomm). Qualcomm runs the higher net margin — 24.5% vs 16.9%, a 7.6% gap on every dollar of revenue. On growth, ASTRAZENECA PLC posted the faster year-over-year revenue change (11.7% vs 5.0%).

AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

Qualcomm Incorporated is an American multinational corporation headquartered in San Diego, California, and incorporated in Delaware. It creates semiconductors, software and services related to wireless technology. It owns patents critical to the 5G, 4G, CDMA2000, TD-SCDMA and WCDMA mobile communications standards.

AZN vs QCOM — Head-to-Head

Bigger by revenue
AZN
AZN
1.2× larger
AZN
$14.5B
$12.3B
QCOM
Growing faster (revenue YoY)
AZN
AZN
+6.7% gap
AZN
11.7%
5.0%
QCOM
Higher net margin
QCOM
QCOM
7.6% more per $
QCOM
24.5%
16.9%
AZN

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
AZN
AZN
QCOM
QCOM
Revenue
$14.5B
$12.3B
Net Profit
$2.4B
$3.0B
Gross Margin
82.9%
54.6%
Operating Margin
24.3%
27.5%
Net Margin
16.9%
24.5%
Revenue YoY
11.7%
5.0%
Net Profit YoY
27.0%
-5.5%
EPS (diluted)
$1.57
$2.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AZN
AZN
QCOM
QCOM
Q4 25
$12.3B
Q3 25
$11.3B
Q2 25
$14.5B
$10.4B
Q1 25
$11.0B
Q4 24
$11.7B
Q3 24
$10.2B
Q2 24
$12.9B
$9.4B
Q1 24
$9.4B
Net Profit
AZN
AZN
QCOM
QCOM
Q4 25
$3.0B
Q3 25
$-3.1B
Q2 25
$2.4B
$2.7B
Q1 25
$2.8B
Q4 24
$3.2B
Q3 24
$2.9B
Q2 24
$1.9B
$2.1B
Q1 24
$2.3B
Gross Margin
AZN
AZN
QCOM
QCOM
Q4 25
54.6%
Q3 25
55.3%
Q2 25
82.9%
55.6%
Q1 25
55.0%
Q4 24
55.8%
Q3 24
56.4%
Q2 24
83.1%
55.6%
Q1 24
56.3%
Operating Margin
AZN
AZN
QCOM
QCOM
Q4 25
27.5%
Q3 25
25.9%
Q2 25
24.3%
26.6%
Q1 25
28.4%
Q4 24
30.5%
Q3 24
25.2%
Q2 24
21.2%
23.6%
Q1 24
24.9%
Net Margin
AZN
AZN
QCOM
QCOM
Q4 25
24.5%
Q3 25
-27.7%
Q2 25
16.9%
25.7%
Q1 25
25.6%
Q4 24
27.3%
Q3 24
28.5%
Q2 24
14.9%
22.7%
Q1 24
24.8%
EPS (diluted)
AZN
AZN
QCOM
QCOM
Q4 25
$2.78
Q3 25
$-2.77
Q2 25
$1.57
$2.43
Q1 25
$2.52
Q4 24
$2.83
Q3 24
$2.57
Q2 24
$1.24
$1.88
Q1 24
$2.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AZN
AZN
QCOM
QCOM
Cash + ST InvestmentsLiquidity on hand
$7.1B
$11.8B
Total DebtLower is stronger
$14.8B
Stockholders' EquityBook value
$44.8B
$23.1B
Total Assets
$112.4B
$53.0B
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AZN
AZN
QCOM
QCOM
Q4 25
$11.8B
Q3 25
$10.2B
Q2 25
$7.1B
$10.0B
Q1 25
$13.8B
Q4 24
$14.3B
Q3 24
$13.3B
Q2 24
$6.9B
$13.0B
Q1 24
$13.9B
Total Debt
AZN
AZN
QCOM
QCOM
Q4 25
$14.8B
Q3 25
$14.8B
Q2 25
$14.8B
Q1 25
$13.3B
Q4 24
$13.2B
Q3 24
$13.3B
Q2 24
$13.2B
Q1 24
$14.5B
Stockholders' Equity
AZN
AZN
QCOM
QCOM
Q4 25
$23.1B
Q3 25
$21.2B
Q2 25
$44.8B
$27.2B
Q1 25
$27.7B
Q4 24
$26.9B
Q3 24
$26.3B
Q2 24
$39.6B
$24.7B
Q1 24
$24.5B
Total Assets
AZN
AZN
QCOM
QCOM
Q4 25
$53.0B
Q3 25
$50.1B
Q2 25
$112.4B
$54.9B
Q1 25
$55.4B
Q4 24
$55.6B
Q3 24
$55.2B
Q2 24
$104.3B
$52.7B
Q1 24
$53.2B
Debt / Equity
AZN
AZN
QCOM
QCOM
Q4 25
0.64×
Q3 25
0.70×
Q2 25
0.54×
Q1 25
0.48×
Q4 24
0.49×
Q3 24
0.51×
Q2 24
0.53×
Q1 24
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AZN
AZN
QCOM
QCOM
Operating Cash FlowLast quarter
$5.0B
Free Cash FlowOCF − Capex
$4.4B
FCF MarginFCF / Revenue
36.0%
Capex IntensityCapex / Revenue
4.5%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$12.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AZN
AZN
QCOM
QCOM
Q4 25
$5.0B
Q3 25
$4.0B
Q2 25
$2.9B
Q1 25
$2.6B
Q4 24
$4.6B
Q3 24
$2.6B
Q2 24
$3.1B
Q1 24
$3.6B
Free Cash Flow
AZN
AZN
QCOM
QCOM
Q4 25
$4.4B
Q3 25
$3.6B
Q2 25
$2.6B
Q1 25
$2.3B
Q4 24
$4.3B
Q3 24
$2.4B
Q2 24
$2.7B
Q1 24
$3.4B
FCF Margin
AZN
AZN
QCOM
QCOM
Q4 25
36.0%
Q3 25
31.8%
Q2 25
24.9%
Q1 25
21.3%
Q4 24
36.9%
Q3 24
23.3%
Q2 24
28.4%
Q1 24
35.9%
Capex Intensity
AZN
AZN
QCOM
QCOM
Q4 25
4.5%
Q3 25
3.6%
Q2 25
2.8%
Q1 25
1.9%
Q4 24
2.4%
Q3 24
2.5%
Q2 24
4.1%
Q1 24
2.0%
Cash Conversion
AZN
AZN
QCOM
QCOM
Q4 25
1.65×
Q3 25
Q2 25
1.08×
Q1 25
0.91×
Q4 24
1.44×
Q3 24
0.91×
Q2 24
1.43×
Q1 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AZN
AZN

Segment breakdown not available.

QCOM
QCOM

Handsets$7.8B64%
Io T$1.7B14%
Qtl$1.6B13%
Automotive$1.1B9%

Related Comparisons